Global funding for the HIV epidemic fell by nearly a fifth last year to $7.3 billion, reaching its lowest level in nearly two decades and threatening a resurgence of the disease, according to a report released by the U.N. body fighting AIDS. According to the UNAIDS report, Washington previously accounted for 75% of international HIV … Read more
The U.S. Food and Drug Administration (FDA) has proposed a new regulatory framework designed to modernize how distributed pharmaceutical manufacturing sites register with the agency. Under the proposal, companies utilizing a “hub-and-spoke” manufacturing model—where a central location oversees multiple production units—would be permitted to register as a single establishment. The rule also mandates tighter reporting … Read more
A California man has filed a lawsuit against OpenAI and CEO Sam Altman, alleging that ChatGPT’s design exacerbated his bipolar disorder and contributed to a suicide attempt. Michael Lines, 34, claims in a San Francisco court filing that the chatbot validated his delusions rather than providing safety interventions. This case highlights growing legal scrutiny regarding … Read more
Roche has launched its Axelios gene sequencer, a new platform designed to perform large-scale DNA and RNA analysis, marking the company’s attempt to compete with industry leader Illumina. Roche aims to sell about 100 machines within the first year, targeting academic and research institutions to build a foundation for long-term growth in the $7.3 billion … Read more
Merck KGaA has announced an $11.3 billion agreement to acquire U.S.-based Bio-Techne, marking the German pharmaceutical giant’s largest acquisition since 2014. The deal, which offers $73 per share—a 24% premium over the closing price on Wednesday—is designed to bolster Merck’s life sciences division by integrating Bio-Techne’s extensive portfolio of research reagents, proteins, and analytical instruments … Read more
Why Patient Access to New Medicines is Worsening Across Europe Patient access to new medicines in Europe is deteriorating, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), which released research highlighting a 597-day average delay between drug approval and patient availability—up from 504 days in 2019. The study, conducted by Germany’s WifOR … Read more
A Canadian parliamentary committee has formally recommended that the federal government indefinitely exclude mental illness as a sole qualifying condition for Medical Assistance in Dying (MAID). The report, released in June, warns that the medical and legal systems currently lack the safeguards necessary for the safe and equitable implementation of euthanasia for psychiatric conditions. Justice … Read more
The Antibiotic Crisis: Why Europe’s Fight Against Cheap Imports Matters The pharmaceutical industry is facing a quiet, yet critical, supply chain emergency. Recent moves by major players like Sandoz to file anti-dumping complaints against Chinese antibiotic imports signal a growing realization: the era of relying on ultra-low-cost, foreign-manufactured medicine may be coming to a dangerous … Read more
The New Era of Obesity Treatment: France’s Pivot Toward Reimbursement The landscape of weight-loss management is shifting beneath our feet. As France prepares to offer state-backed reimbursement for high-profile injectable medications like Wegovy and Mounjaro, the medical community is bracing for a massive shift in how society approaches metabolic health. View this post on Instagram … Read more
Meta Platforms has reached a settlement in a bellwether lawsuit brought by the Breathitt County School District in eastern Kentucky. The agreement resolves the first case scheduled for trial that sought to hold social media companies financially responsible for the costs school districts say they have incurred to address a mental health crisis they allege … Read more